COGNITION THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT March 20, 2014Investors’ Rights Agreement • July 19th, 2021 • Cognition Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 19th, 2021 Company Industry JurisdictionTHIS THIRD AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 20th day of March, 2014, by and among Cognition Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of whom is referred to in this Agreement as an “Investor” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9.
AXCELLA HEALTH INC. FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • April 12th, 2019 • Axcella Health Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 12th, 2019 Company Industry JurisdictionTHIS FIFTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT is made as of the 30th day of November, 2018, by and among Axcella Health Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto and any subsequent purchasers of Preferred Stock who become parties hereto as “Investor” pursuant to Section 6.10 below, each of which is referred to in this Agreement as an “Investor”.
WOODMAN LABS, INC. INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • May 19th, 2014 • GoPro, Inc. • Photographic equipment & supplies • California
Contract Type FiledMay 19th, 2014 Company Industry JurisdictionThis Investors’ Rights Agreement (this “Agreement”) is made as of February 25, 2011, by and among Woodman Labs, Inc. (d/b/a GoPro), a California corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”).